Authors

• Jeffrey Yachnin (ORCID: https://orcid.org/0009-0009-3656-9657)
• Taina Turpeenniemi‐Hujanen
• Patrick Neven (ORCID: https://orcid.org/0000-0002-1434-9460)
• Päivi Halonen (ORCID: https://orcid.org/0000-0002-9760-0840)
• Helena Granstam-Björneklett
• Päivi Auvinen (ORCID: https://orcid.org/0000-0002-2392-9395)
• Minna Tanner (ORCID: https://orcid.org/0000-0002-3012-8641)
• Riikka Huovinen
• Meri Utriainen (ORCID: https://orcid.org/0000-0002-6727-2268)
• Henrik Lindman (ORCID: https://orcid.org/0000-0002-5871-268X)
• Judith Fraser
• Liisa Sailas
• Teppo Huttunen
• Heikki Joensuu (ORCID: https://orcid.org/0000-0003-0281-2507)
• Hans Wildiers
• Pirkko‐Liisa Kellokumpu‐Lehtinen
• Vernon Harvey
• Kenneth Villman
• Peter Canney

Institutions

• Karolinska University Hospital (SE)
• University of Helsinki (FI)
• Uppsala University Hospital (SE)
• Oulu University Hospital (FI)
• Beatson West of Scotland Cancer Centre (GB)
• Helsinki University Hospital (FI)
• Auckland City Hospital (NZ)
• Turku University Hospital (FI)
• North Karelia Central Hospital (FI)
• Kuopio University Hospital (FI)
• Vaasa Central Hospital (FI)
• Västerås Municipality (SE)
• Tampere University Hospital (FI)
• Örebro University Hospital (SE)
• Tampere University (FI)
• KU Leuven (BE)

Publication Details

Journal

JAMA Network Open

Published

2024-08-26

DOI

https://doi.org/10.1001/jamanetworkopen.2024.29772

Citations

1

Primary Topic

HER2/EGFR in Cancer Research

Type

article

Field-Weighted Citation Impact

0.28

Funders

• Sanofi
• Sigrid Juséliuksen Säätiö
• Syöpäjärjestöt